Visit COVID-19 resources

[Skip to Content]


Use of Anti VEGF agents in children

Dec 29

Statement from the College’s Paediatric Sub-committee; October 2014.

  • 29 December 2014

Choice of anti VEGF agents for wet AMD treatments

Dec 22

College statement on choice of two antiVEGF agents for the treatment of wet AMD, following NICE guidance on Ranibizumab (TA155) and Aflibercept (TA294). March2014

  • 22 December 2014